We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Ampronix,  Inc


Medtronic offers medical products and therapies for the treatment of cardiac and vascular diseases, diabetes, and neu... read more Featured Products: More products

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
24 Feb 2021 - 28 Feb 2021
Virtual Venue

Smart Insulin Pen Helps Users Make Better Dosing Decisions

By HospiMedica International staff writers
Posted on 26 Nov 2020
Print article
Image: The InPen smart insulin pen and Companion app (Photo courtesy of Medtronic)
Image: The InPen smart insulin pen and Companion app (Photo courtesy of Medtronic)
An integrated system provides real-time glucose readings alongside insulin dose information for people on multiple daily injections (MDI).

The Medtronic (Dublin, Ireland) InPen with Guardian Connect links wirelessly to a smartphone device in order to provide dosing calculations and reminders, integrating concomitantly with continuous glucose monitoring (CGM) systems. The companion app tracks insulin doses, active insulin, and recommendations on meal time and correct dosing. The integration with Medtronic CGMs allows patients to see all their information in one view, and share the data with caregivers and clinicians.

The InPen is compatible with short-acting Humalog, Novolog, and Fiasp U-100 3.0 mL insulin cartridges. The InPen app also allows users to manually log long-acting insulin doses and set up dose reminders. A built-in customizable calculator helps choose among three different modes, based on carbohydrate content. Additional features include temperature monitoring, an automated month-long notebook, and integration with most Bluetooth-connected glucose meters. Multiple InPens can be connected to a single app.

“We’re pleased to build on the success of InPen with added real-time glucose data, which provides a complete picture for users as they look to give themselves the right dose of insulin at the right time,” said Sean Salmon, executive VP and president of the diabetes business at Medtronic. “Our successful integration of these devices in just two months following the close of Companion Medical acquisition is a testament to the close collaboration of our employees and strong passion to serve our customers with better solutions to manage their diabetes.”

The traditional standard-of-care for glucose monitoring is a finger stick meter. CGM thus represents the most significant breakthrough in diabetes management in the past 40 years, augmenting the use of glucose meters for the management of diabetes by providing real-time glucose changes with the push of a button, alerting users when glucose is too low or too high.

Print article



view channel

Hillrom Acquires Bardy Diagnostics to Expand into Ambulatory Cardiac Monitoring Segment

Hillrom (Chicago, IL, USA) has reached a definitive agreement to acquire Bardy Diagnostics, Inc. (BardyDx; Seattle, WA, USA) for a cash consideration of USD 375 million. The acquisition of BardyDx,... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.